These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 16707486

  • 1. Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression.
    Yamagishi S, Nakamura K, Matsui T, Inagaki Y, Takenaka K, Jinnouchi Y, Yoshida Y, Matsuura T, Narama I, Motomiya Y, Takeuchi M, Inoue H, Yoshimura A, Bucala R, Imaizumi T.
    J Biol Chem; 2006 Jul 21; 281(29):20213-20. PubMed ID: 16707486
    [Abstract] [Full Text] [Related]

  • 2. Pigment epithelium-derived factor inhibits advanced glycation end products-induced retinal vascular permeability.
    Sheikpranbabu S, Haribalaganesh R, Lee KJ, Gurunathan S.
    Biochimie; 2010 Aug 21; 92(8):1040-51. PubMed ID: 20470857
    [Abstract] [Full Text] [Related]

  • 3. Protective effect of perindopril on diabetic retinopathy is associated with decreased vascular endothelial growth factor-to-pigment epithelium-derived factor ratio: involvement of a mitochondria-reactive oxygen species pathway.
    Zheng Z, Chen H, Ke G, Fan Y, Zou H, Sun X, Gu Q, Xu X, Ho PC.
    Diabetes; 2009 Apr 21; 58(4):954-64. PubMed ID: 19188429
    [Abstract] [Full Text] [Related]

  • 4. Pigment epithelium-derived factor (PEDF) prevents diabetes- or advanced glycation end products (AGE)-elicited retinal leukostasis.
    Yamagishi S, Matsui T, Nakamura K, Takeuchi M, Imaizumi T.
    Microvasc Res; 2006 Apr 21; 72(1-2):86-90. PubMed ID: 16797605
    [Abstract] [Full Text] [Related]

  • 5. Protective role of pigment epithelium-derived factor (PEDF) in early phase of experimental diabetic retinopathy.
    Yoshida Y, Yamagishi S, Matsui T, Jinnouchi Y, Fukami K, Imaizumi T, Yamakawa R.
    Diabetes Metab Res Rev; 2009 Oct 21; 25(7):678-86. PubMed ID: 19685553
    [Abstract] [Full Text] [Related]

  • 6. Pigment epithelium-derived factor inhibits neointimal hyperplasia after vascular injury by blocking NADPH oxidase-mediated reactive oxygen species generation.
    Nakamura K, Yamagishi S, Matsui T, Yoshida T, Takenaka K, Jinnouchi Y, Yoshida Y, Ueda S, Adachi H, Imaizumi T.
    Am J Pathol; 2007 Jun 21; 170(6):2159-70. PubMed ID: 17525281
    [Abstract] [Full Text] [Related]

  • 7. Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF.
    Yamagishi S, Nakamura K, Ueda S, Kato S, Imaizumi T.
    Cell Tissue Res; 2005 Jun 21; 320(3):437-45. PubMed ID: 15846509
    [Abstract] [Full Text] [Related]

  • 8. Pigment epithelium-derived factor inhibits advanced glycation end product-elicited mesangial cell damage by blocking NF-kappaB activation.
    Ide Y, Matsui T, Ishibashi Y, Takeuchi M, Yamagishi S.
    Microvasc Res; 2010 Sep 21; 80(2):227-32. PubMed ID: 20381502
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of JAK2/STAT3-mediated VEGF upregulation under high glucose conditions by PEDF through a mitochondrial ROS pathway in vitro.
    Zheng Z, Chen H, Zhao H, Liu K, Luo D, Chen Y, Chen Y, Yang X, Gu Q, Xu X.
    Invest Ophthalmol Vis Sci; 2010 Jan 21; 51(1):64-71. PubMed ID: 19696171
    [Abstract] [Full Text] [Related]

  • 10. Pigment epithelium-derived factor inhibits vascular endothelial growth factor-induced vascular hyperpermeability both in vitro and in vivo.
    Yamagishi S, Abe R, Jinnouchi Y, Matsui T, Imaizumi T, Inoue H.
    J Int Med Res; 2007 Jan 21; 35(6):896-9. PubMed ID: 18084849
    [Abstract] [Full Text] [Related]

  • 11. PEDF inhibits VEGF- and EPO- induced angiogenesis in retinal endothelial cells through interruption of PI3K/Akt phosphorylation.
    Elayappan B, Ravinarayannan H, Pasha SP, Lee KJ, Gurunathan S.
    Angiogenesis; 2009 Jan 21; 12(4):313-24. PubMed ID: 19657716
    [Abstract] [Full Text] [Related]

  • 12. Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties.
    Yamagishi S, Inagaki Y, Amano S, Okamoto T, Takeuchi M, Makita Z.
    Biochem Biophys Res Commun; 2002 Aug 30; 296(4):877-82. PubMed ID: 12200129
    [Abstract] [Full Text] [Related]

  • 13. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
    Zhang SX, Wang JJ, Gao G, Parke K, Ma JX.
    J Mol Endocrinol; 2006 Aug 30; 37(1):1-12. PubMed ID: 16901919
    [Abstract] [Full Text] [Related]

  • 14. Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.
    Yamagishi S, Matsui T, Nakamura K, Yoshida T, Takeuchi M, Inoue H, Yoshida Y, Imaizumi T.
    Ophthalmic Res; 2007 Aug 30; 39(2):92-7. PubMed ID: 17284935
    [Abstract] [Full Text] [Related]

  • 15. Pigment epithelium-derived factor inhibits TNF-alpha-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation.
    Yamagishi S, Inagaki Y, Nakamura K, Abe R, Shimizu T, Yoshimura A, Imaizumi T.
    J Mol Cell Cardiol; 2004 Aug 30; 37(2):497-506. PubMed ID: 15276019
    [Abstract] [Full Text] [Related]

  • 16. Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.
    Fujimura T, Yamagishi S, Ueda S, Fukami K, Shibata R, Matsumoto Y, Kaida Y, Hayashida A, Koike K, Matsui T, Nakamura K, Okuda S.
    Nephrol Dial Transplant; 2009 May 30; 24(5):1397-406. PubMed ID: 19042927
    [Abstract] [Full Text] [Related]

  • 17. Administration of pigment epithelium-derived factor (PEDF) inhibits cold injury-induced brain edema in mice.
    Jinnouchi Y, Yamagishi S, Matsui T, Takenaka K, Yoshida Y, Nakamura K, Ueda S, Imaizumi T.
    Brain Res; 2007 Sep 05; 1167():92-100. PubMed ID: 17692294
    [Abstract] [Full Text] [Related]

  • 18. Pigment epithelium-derived factor inhibits advanced glycation end-products-induced cytotoxicity in retinal pericytes.
    Sheikpranbabu S, Haribalaganesh R, Gurunathan S.
    Diabetes Metab; 2011 Dec 05; 37(6):505-11. PubMed ID: 21636306
    [Abstract] [Full Text] [Related]

  • 19. Pigment epithelium-derived factor maintains retinal pigment epithelium function by inhibiting vascular endothelial growth factor-R2 signaling through gamma-secretase.
    Ablonczy Z, Prakasam A, Fant J, Fauq A, Crosson C, Sambamurti K.
    J Biol Chem; 2009 Oct 30; 284(44):30177-86. PubMed ID: 19723623
    [Abstract] [Full Text] [Related]

  • 20. Pigment epithelium-derived factor inhibits leptin-induced angiogenesis by suppressing vascular endothelial growth factor gene expression through anti-oxidative properties.
    Yamagishi S, Amano S, Inagaki Y, Okamoto T, Takeuchi M, Inoue H.
    Microvasc Res; 2003 May 30; 65(3):186-90. PubMed ID: 12711260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.